Joseph Lewis serves as Executive at Somaxon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Joseph Lewis has executed 62 insider transactions totaling $207.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 28, 2019 involved exercising options for 3,166,275 shares valued at $8.0M.
Joseph Lewis currently holds 52,771 shares of Somaxon Pharmaceuticals, Inc. (SOMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph Lewis has been a net seller of SOMX stock. They have purchased $48.9M and sold $158.1M worth of shares.
Joseph Lewis's most recent insider trade was on Mar 28, 2019, when they sold 3,166,275 shares at $2.52 per share.
Get notified when new Form 4 filings are submitted
| $3.00 |
| Discretionary |
| Oct 24, 2018 | ODT | $394.8K | Purchase | 26,824 | $14.72 | Discretionary |
| Mar 26, 2018 | ODT | $754.1K | Purchase | 33,650 | $22.41 | Discretionary |
| Mar 23, 2018 | ODT | $1.0M | Purchase | 42,943 | $23.96 | Discretionary |
| Mar 22, 2018 | ODT | $490.1K | Purchase | 23,407 | $20.94 | Discretionary |
| Dec 6, 2017 | ODT | $10.0M | Purchase | 416,666 | $24.00 | Discretionary |
| Jan 4, 2016 | MRTX | $0 | Other | 522,500 | $N/A | Discretionary |
| Dec 15, 2014 | SPHS | $486.0K | Sale | 796,772 | $0.61 | Discretionary |
| Dec 15, 2014 | SPHS | $51.7K | Sale | 84,707 | $0.61 | Discretionary |
| Aug 26, 2009 | SOMX | $250.8K | Sale | 95,000 | $2.64 | Discretionary |
| Jul 27, 2009 | SOMX | $1.6M | Sale | 500,000 | $3.10 | Discretionary |